Therapy with imatinib mesylate (Glivec) preceding allogeneic stem cell transplantation (SCT) in relapsed or refractory Philadelphia-positive acute lymphoblastic leukemia (Ph+ALL)
- 26 November 2002
- journal article
- clinical trial
- Published by Springer Nature in Leukemia
- Vol. 16 (12) , 2358-2365
- https://doi.org/10.1038/sj.leu.2402770
Abstract
No abstract availableKeywords
This publication has 15 references indexed in Scilit:
- A phase 2 study of imatinib in patients with relapsed or refractory Philadelphia chromosome-positive acute lymphoid leukemiasBlood, 2002
- BCR-ABL gene mutations in relation to clinical resistance of Philadelphia-chromosome-positive leukaemia to STI571: a prospective studyThe Lancet, 2002
- Activity of a Specific Inhibitor of the BCR-ABL Tyrosine Kinase in the Blast Crisis of Chronic Myeloid Leukemia and Acute Lymphoblastic Leukemia with the Philadelphia ChromosomeNew England Journal of Medicine, 2001
- Unrelated marrow transplantation for adult patients with poor-risk acute lymphoblastic leukemia: strong graft-versus-leukemia effect and risk factors determining outcomeBlood, 2001
- Salvage Therapy for Refractory or Relapsed Acute Lymphocytic LeukemiaHematology/Oncology Clinics of North America, 2001
- Allogeneic Stem Cell Transplantation for Acute Lymphocytic Leukemia in AdultsHematology/Oncology Clinics of North America, 2001
- Philadelphia Chromosome–Positive Acute Lymphocytic LeukemiaHematology/Oncology Clinics of North America, 2001
- TREATMENT OF ADULT ALL ACCORDING TO PROTOCOLS OF THE GERMAN MULTICENTER STUDY GROUP FOR ADULT ALL (GMALL)Hematology/Oncology Clinics of North America, 2000
- Long-term follow-up of 23 patients with Philadelphia chromosome-positive acute lymphoblastic leukemia treated with allogeneic bone marrow transplant in first complete remissionLeukemia, 1999
- Marrow Transplants From Unrelated Donors for Treatment of Philadelphia Chromosome-Positive Acute Lymphoblastic LeukemiaBlood, 1997